EP2606070
Mótefni fyrir viðtaka 3 fyrir þekjufrumuvaxtarþátt (HER3)
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.8.2011EP published:
21.12.2016EP application number:
11746252.3
EP translation filed:
8.3.2017Grant published:
15.4.2017EPO information:
European Patent Register
Max expiry date:
21.8.2031Expiry date:
21.8.2022
Title:
ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
Timeline
Today
22.8.2011EP application
21.12.2016EP Publication
8.3.2017Translation submitted
15.4.2017Registration published
21.8.2022Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
ELIS, WinfriedAddress:
Planegg, DE
Name:
ETTENBERG, SethAddress:
Massachusetts, US
Name:
GARNER, Andrew PaulAddress:
Massachusetts, US
Name:
HAUBST, NicoleAddress:
Planegg, DE
Name:
KUNZ, Christian Carsten SilvesterAddress:
Planegg, DE
Name:
REISINGER SPRAGUE, Elizabeth AnneAddress:
Massachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
375408 PDate:
20.8.2010Country:
US
Classification
Categories:
C07K 16/32, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 25.7.2017
Expires: 21.8.2018
Payer: Árnason Faktor
Number: 8
Paid: 25.7.2018
Expires: 21.8.2019
Payer: Árnason Faktor
Number: 9
Paid: 23.7.2019
Expires: 21.8.2020
Payer: Árnason Faktor
Number: 10
Paid: 24.7.2020
Expires: 21.8.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 23.7.2021
Expires: 21.8.2022
Payer: Árnason Faktor ehf.